Bluelinx Holdings Inc (BXC)

$18.14 0.18 (0.98%)

19:00 EDT BXC Stock Quote Delayed 30 Minutes

Volume:

Previous Close $18.14

Market Cap 167.07M

PE Ratio 3.43

EPS 5.283108

Volume (Avg. Vol.) 146,200

Day's Range 17.10 - 18.44

52-Week Range 3.60 - 35.40

Dividend & Yield N/A (N/A)

BXC Stock Predictions, Articles, and Bluelinx Holdings Inc News

From the Web

3 Best Coronavirus Vaccine Stocks to Buy Right Now

From The Motley Fool Sep 20, 2020

You don't have to take on a huge amount of risk to profit from these solid COVID-19 vaccine leaders.

Better Coronavirus Stock: AstraZeneca or Moderna?

From The Motley Fool Sep 19, 2020

The risk-reward profiles of these COVID-19 vaccine leaders are very different.

Wildfires Leave Insurers With a Bill for $3 Billion—and Counting

From Barron's Sep 19, 2020

The fires continue to rage. The good news: many of the 40,000 fires are far from expensive coast areas. But the damage is immense, the smoke could produce other costs, and reinsurance rates are rising.

Heavy Flows Into And Out Of Markets

From Talk Markets Sep 18, 2020

Today is a quadruple witching hour in US markets with stock, and stock index moves to end for the month, and index and stock options also ending for the quarter. This brings volatility.

AstraZeneca's Lynparza Delivers Progression-Free Survival of Over 4 Years in Advanced Ovarian Cancer

From The Motley Fool Sep 18, 2020

The latest results from a long-term study of the drug enhance the case for its use.

Pharma Stock Roundup: AZN, LLY & PFE's Coronavirus Updates, MRK's New Cancer Deals

From Zacks Investment Research Sep 18, 2020

AstraZeneca (AZN) resumes its coronavirus vaccine study in the United Kingdom. Merck (MRK) inks two oncology deals with Seattle Genetics.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold